West Pharmaceutical Services to Transfer SmartDose® Technology to AbbVie in Strategic Deal West Pharmaceutical Services has agreed to sell its SmartDose® 3.5mL On-Body Delivery System rights to AbbVie for $112.5 million, enhancing future growth opportunities.

West Pharmaceutical Services to Transfer SmartDose® Technology to AbbVie in Strategic Deal #United_States #Exton #AbbVie #West_Pharmaceutical #SmartDose